SGLT2 INHIBITORS, KETONES, & CARDIOVASCULAR BENEFIT CTMS 18-0009

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

DeFronzo, Ralph A

Funded by

MERCK SHARP & DOHME RESEARCH LTD

Research Start Date

01/01/2019

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Bioscience Research Panel